Search research articles
Contact Us
Filters
Showing results (11-20 of 98) with videos related to
Page
of 10
Sort By:
Vaccines
|
July 26, 2018
<i>Listeria monocytogenes</i> as a Vector for Cancer Immunotherapy: Current Understanding and Progress
John C Flickinger, Ulrich Rodeck, Adam E Snook
Immunotherapy
|
March 16, 2021
Vaccines and immune checkpoint inhibitors: a promising combination strategy in gastrointestinal cancers
Babar Bashir, John C Flickinger, Adam E Snook
Personalized Medicine
|
February 10, 2021
Stem cells as therapeutic targets in colorectal cancer
Alicja Zalewski, Adam E Snook, Scott A Waldman
Biomarkers in Medicine
|
May 14, 2021
Emerging targets for the diagnosis of Parkinson's disease: examination of systemic biomarkers
Lara Cheslow, Adam E Snook, Scott A Waldman
Immunotherapy
|
December 5, 2022
The poorly immunogenic tumor microenvironment of pancreatic cancer: the impact of radiation therapy, and strategies targeting resistance
Robert Hughes, Adam E Snook, Adam C Mueller
Toxins
|
June 27, 2020
Mobilizing Toxins for Cancer Treatment: Historical Perspectives and Current Strategies
Jessica Kopenhaver, Robert D Carlson, Adam E Snook
Biomolecules
|
April 27, 2024
Biomarkers for Managing Neurodegenerative Diseases
Lara Cheslow, Adam E Snook, Scott A Waldman
Cancer Biology & Therapy
|
February 7, 2022
Targeting gastrointestinal cancers with chimeric antigen receptor (CAR)-T cell therapy
Ross E Staudt, Robert D Carlson, Adam E Snook
Expert Review of Clinical Pharmacology
|
October 19, 2022
Overview of predictive and prognostic biomarkers and their importance in developing a clinical pharmacology treatment plan in colorectal cancer patients
Madison M Crutcher, Adam E Snook, Scott A Waldman
Expert Opinion on Therapeutic Targets
|
May 31, 2021
Guanylyl cyclase 2C (GUCY2C) in gastrointestinal cancers: recent innovations and therapeutic potential
Ariana A Entezari, Adam E Snook, Scott A Waldman
Page
of 10
Search research articles
Search
Showing results (11-20 of 98) with videos related to
Sort By:
Page
of 10
Vaccines
|
July 26, 2018
<i>Listeria monocytogenes</i> as a Vector for Cancer Immunotherapy: Current Understanding and Progress
John C Flickinger, Ulrich Rodeck, Adam E Snook
Immunotherapy
|
March 16, 2021
Vaccines and immune checkpoint inhibitors: a promising combination strategy in gastrointestinal cancers
Babar Bashir, John C Flickinger, Adam E Snook
Personalized Medicine
|
February 10, 2021
Stem cells as therapeutic targets in colorectal cancer
Alicja Zalewski, Adam E Snook, Scott A Waldman
Biomarkers in Medicine
|
May 14, 2021
Emerging targets for the diagnosis of Parkinson's disease: examination of systemic biomarkers
Lara Cheslow, Adam E Snook, Scott A Waldman
Immunotherapy
|
December 5, 2022
The poorly immunogenic tumor microenvironment of pancreatic cancer: the impact of radiation therapy, and strategies targeting resistance
Robert Hughes, Adam E Snook, Adam C Mueller
Toxins
|
June 27, 2020
Mobilizing Toxins for Cancer Treatment: Historical Perspectives and Current Strategies
Jessica Kopenhaver, Robert D Carlson, Adam E Snook
Biomolecules
|
April 27, 2024
Biomarkers for Managing Neurodegenerative Diseases
Lara Cheslow, Adam E Snook, Scott A Waldman
Cancer Biology & Therapy
|
February 7, 2022
Targeting gastrointestinal cancers with chimeric antigen receptor (CAR)-T cell therapy
Ross E Staudt, Robert D Carlson, Adam E Snook
Expert Review of Clinical Pharmacology
|
October 19, 2022
Overview of predictive and prognostic biomarkers and their importance in developing a clinical pharmacology treatment plan in colorectal cancer patients
Madison M Crutcher, Adam E Snook, Scott A Waldman
Expert Opinion on Therapeutic Targets
|
May 31, 2021
Guanylyl cyclase 2C (GUCY2C) in gastrointestinal cancers: recent innovations and therapeutic potential
Ariana A Entezari, Adam E Snook, Scott A Waldman
Page
of 10